Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acer MedicalROCO:6857 +2.22%51 Receivables Turnover is 2.69 as of Dec. 2025. GuruFocus rates ROCO:6857 with a GF Score™ of 51/100 and a GF Value™ of NT$266.85 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Acer Medical ranks worse than 66.06% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Acer Medical's Revenue for the
six
months ended in Dec. 2025 was NT$29.93 Mil. Acer Medical's average Accounts Receivable for the
six
months ended in Dec. 2025 was NT$11.12 Mil.
Hence, Acer Medical's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.69.
Acer Medical (ROCO:6857) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Acer Medical Receivables Turnover Related Terms
Acer Medical Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Acer Medical's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6857 vs VEEV, BTSG, HQY: Receivables Turnover Comparison
For the Health Information Services subindustry, Acer Medical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Acer Medical's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acer Medical (ROCO:6857) has a Receivables Turnover of 2.69 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Acer Medical and its competitors. According to the industry distribution chart, Acer Medical ranks #436 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 66.1%.
Is Acer Medical's Receivables Turnover too high?
Acer Medical's current Receivables Turnover is 2.69. The Healthcare Providers & Services industry median Receivables Turnover is 7.95. Acer Medical's value of 2.69 is 66.2% below this industry median. Based on the distribution chart, Acer Medical ranks #436 out of 660 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Acer Medical has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's Receivables Turnover compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #436 out of 660 companies for Receivables Turnover. This places Acer Medical in the lower half of its industry. The industry median Receivables Turnover is 7.95. Acer Medical's value of 2.69 is 66.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.95, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acer Medical's current Receivables Turnover of 2.69 is 66.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Acer Medical and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current Receivables Turnover is 2.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$266.85, compared to a current price of NT$92.00 — trading 65.5% below its estimated fair value. The current Receivables Turnover is 2.69 and 66.2% below the Healthcare Providers & Services industry median of 7.95. Acer Medical's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current Receivables Turnover is 2.69 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$92.00 is trading 65.5% below its estimated GF Value™ of NT$266.85.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
Receivables Turnover: 2.69
GF Value™: NT$266.85 vs. price of NT$92.00 (65.5% below fair value)
Industry Position: 66.2% below the Healthcare Providers & Services median (#436 of 660)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
51GF Score
Get the complete analysis for ROCO:6857
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
